Services

Life Sciences Arbitration

Overview

CRA’s life sciences arbitration support is grounded in a comprehensive, insiders’ understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 25 years, we have consulted directly with major life science companies, law firms, and regulatory agencies around the globe. This deep industry knowledge is complemented by our extensive experience in complex litigation. CRA’s involvement has helped our clients solve their most challenging strategic problems and resolve their most contentious disputes.

01

Prospective damages evaluation for breach of a co-promotion agreement

CRA experts were retained on behalf of a multinational biopharmaceutical manufacturer to evaluate expected damages from terminating a co-promotion agreement
View engagement
02

Commercial arbitration involving orphan drug distribution in Colombia

Dr. Tiago Duarte-Silva was retained in a commercial arbitration between a large pharmaceutical company and a drug distributor in Colombia related to the early...
View engagement
03

AAA dispute in commercially reasonable efforts to market a hospital administered drug

CRA expert, Dr. Sean Sheridan considered the Respondent’s efforts as they relate to the obligations of the licensing agreement and evaluated those efforts...
View engagement